http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007016656-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bf6b40220880e3b46fc3b230e03f7d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfae6e97c048865df239daf4acf049a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2755bf36096ae565daccf27e76464fd
publicationDate 2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007016656-A8
titleOfInvention Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders
abstract Methods for treatment of ocular disorders using steroids modulate the effects of local and systemic hypoxic events mediated by hypoxia inducible factor- 1 (HIF-1). Steroids that are useful as HIF-1 modulators include bufalin, digitoxigenin, digoxin, lanatoside C, strophantin K, uzarigenin, ouabain and proscillaridin. In some embodiments the ocular disorder is characterized by ischmia.
priorityDate 2005-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284613
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID141614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4369270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454134668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9547215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226527814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500888
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID141614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID274159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227391024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441853
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCG5EGD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227391025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22821796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226494791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323045

Total number of triples: 57.